Cite
HARVARD Citation
Burns, D. et al. (2021). Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. Lancet neurology. 20 (7), pp. 537-547. [Online].